Psyllium Husk (Isabgol) for Blood Sugar Regulation

Research suggests that psyllium husk supplementation is associated with improvements in multiple markers of blood sugar regulation, including fasting blood glucose, postprandial glucose, HbA1c, and insulin sensitivity, across a range of populations including individuals with type 2 diabetes, metabolic syndrome, and obesity. The evidence base is notably consistent in direction, drawing from two meta-analyses of randomized controlled trials, numerous narrative reviews, interventional studies in humans, and animal model research, all of which point toward meaningful glycemic benefits. The proposed mechanism centers on psyllium's high-viscosity, gel-forming properties in the small intestine, which are thought to slow glucose absorption and blunt the postprandial blood sugar response rather than any effect attributable to soluble fiber broadly defined. Studies indicate that while the overall picture is supportive, some of the evidence relies on smaller interventional studies, animal models, and reviews that vary in methodological rigor, and researchers in earlier work have noted the need for larger, well-controlled trials — particularly in pediatric populations — before conclusions can be considered fully definitive.